Tribbles Genes in Gastric Cancer: A Tumor-Suppressive Role for TRIB2

Alessia Foscarini1,2, Rossella Tricarico1, Federica Gentile1

  • 1Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Genes
|January 23, 2024
PubMed

Insights

Tribbles pseudokinase 2 (TRIB2) shows a tumor-suppressive role in gastric cancer (GC) with chromosomal instability. Lower TRIB2 expression correlates with advanced GC, suggesting its potential as a biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genomics

Background:

  • Tribbles pseudokinases (TRIB1-3) are key signaling modulators implicated in various cancers.
  • The specific role of TRIB genes in gastric cancer (GC) pathogenesis is largely unknown.
  • Gastric cancer lacks sensitive biomarkers for early diagnosis and predicting therapy response, impacting patient outcomes.

Purpose of the Study:

  • To investigate the function of TRIB genes, particularly TRIB2, in gastric tumorigenesis.
  • To explore the potential of TRIB2 as a diagnostic or therapeutic target in GC.
  • To determine the association between TRIB gene expression and GC subtypes (CIN vs. MSI-high).

Main Methods:

  • Utilized TCGA dataset for gene expression analysis in GC tumors.
  • Performed in vitro experiments involving TRIB2 overexpression (OE) in CIN GC cell lines (MKN45, NCI-N87).
  • Assessed cell proliferation, colony formation, cell motility, and cell cycle progression.

Main Results:

  • TCGA data indicated lower TRIB2 expression in chromosomal instability (CIN) tumors compared to microsatellite instability-high (MSI-high) tumors.
  • Low TRIB2 expression was significantly associated with advanced stage IV disease in CIN tumors.
  • TRIB2 OE suppressed proliferation and colony formation in MKN45 cells, inducing G2/M arrest, and reduced proliferation and motility in NCI-N87 cells.
  • The observed effects of TRIB2 OE were independent of the MAPK pathway.

Conclusions:

  • TRIB2 exhibits tumor-suppressive functions in gastric cancer, particularly within the CIN subtype.
  • TRIB2 expression levels may serve as a prognostic biomarker for GC aggressiveness.
  • Further research into TRIB2's mechanisms could unveil novel therapeutic strategies for GC.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K